Moldons Pharmaceuticals UK Pathway to Clinic®

At Moldons Pharmaceuticals UK, we take responsibility for your full phase 1 requirements. Through our Pathway to Clinic® offering, we guide you from formulation development to clinical supply manufacture and trial management.

We understand that you need to get your product successfully through phase 1 as quickly and safely as possible. So to support you, we formed a close partnership with the Clinical Trial Consultants (CTC), experts in conducting hospital-based early phase clinical trials. This allows us to offer a complete, seamless solution, reducing the complexity of your first in human projects.Together with CTC, we pioneer new routes to achieve your first in human milestone. We have complete control over all the links in the chain so you can run activities in parallel, adjust at each step to avoid delays, meet deadlines and build value in your clinical data.

Our Pathway to Clinic services include:

Our priority is to reduce risk, time and cost for our phase 1 customers, delivering regulatory compliant first in human studies. Responsibly guiding you, because we care. Your first in human partner.